Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Inovio Pharmaceuticals, Inc. - Product Pipeline Review - 2012 - New Study ReleasedNew Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research
By: Fast Market Research, Inc. This report is built using data and information sourced from Global Markets Direct's proprietary databases, Inovio Pharmaceuticals, Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from Inovio Pharmaceuticals, Inc. and industry-specific third party sources, put together by Global Markets Direct's team. ------------------------------------------------------------ Full Report Details at - http://www.fastmr.com/ ------------------------------------------------------------ Scope * Inovio Pharmaceuticals, Inc. - Brief Inovio Pharmaceuticals, Inc. overview including business description, key information and facts, and its locations and subsidiaries. * Review of current pipeline of Inovio Pharmaceuticals, Inc. human therapeutic division. * Overview of pipeline therapeutics across various therapy areas. * Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe. * Product profiles for late stage and clinical stage products of Inovio Pharmaceuticals, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones. * Recent updates of the Inovio Pharmaceuticals, Inc.'s pipeline in the last quarter. * Key discontinued and dormant projects. * Latest news and deals relating to the products. Reasons to buy * Evaluate Inovio Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline. * Assess the growth potential of Inovio Pharmaceuticals, Inc. in its therapy areas of focus. * Identify new drug targets and therapeutic classes in the Inovio Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas. * Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps. * Exploit collaboration and partnership opportunities with Inovio Pharmaceuticals, Inc.. * Avoid Intellectual Property Rights related issues. * Explore the dormant and discontinued projects of Inovio Pharmaceuticals, Inc. and identify potential opportunities in those areas. Keywords Current R&D Portfolio of Inovio Pharmaceuticals, Inc.; Inovio Pharmaceuticals, Inc. - Key Therapeutics; Partial Table of Contents: Table of Contents Table of Contents List of Tables List of Figures Inovio Pharmaceuticals, Inc. Snapshot Inovio Pharmaceuticals, Inc. Overview Key Information Key Facts Inovio Pharmaceuticals, Inc. - Research and Development Overview Key Therapeutic Areas Inovio Pharmaceuticals, Inc. - Pipeline Review Pipeline Products by Stage of Development Pipeline Products - Monotherapy Pipeline Products - Combination Treatment Modalities Inovio Pharmaceuticals, Inc. - Pipeline Products Glance Inovio Pharmaceuticals, Inc. Clinical Stage Pipeline Products Phase II Products/Combination Treatment Modalities Phase I Products/Combination Treatment Modalities Inovio Pharmaceuticals, Inc. - Early Stage Pipeline Products Pre-Clinical Products/Combination Treatment Modalities Inovio Pharmaceuticals, Inc. - Drug Profiles DNA Vaccine For Smallpox Product Description Mechanism of Action R&D Progress INO-3401 Product Description Mechanism of Action R&D Progress INO-3605 Product Description Mechanism of Action R&D Progress INO-3605 + INO-3609 Product Description Mechanism of Action R&D Progress INO-3609 Product Description Mechanism of Action R&D Progress INO-5150 Product Description Mechanism of Action R&D Progress INO-8000 Product Description Mechanism of Action R&D Progress PENNVAX-B DNA Vaccine Product Description Mechanism of Action R&D Progress PENNVAX-G Product Description Mechanism of Action R&D Progress PENNVAX-GP Product Description Mechanism of Action R&D Progress PSMA Vaccine Product Description Mechanism of Action R&D Progress SynCon Chikungunya Virus DNA Vaccine Product Description Mechanism of Action R&D Progress SynCon HPV Vaccine Product Description Mechanism of Action R&D Progress Universal Influenza Vaccine Product Description Mechanism of Action R&D Progress V934 Product Description Mechanism of Action R&D Progress VGX-1027 Product Description Mechanism of Action R&D Progress VGX-3100 Product Description Mechanism of Action R&D Progress VGX-3400X Product Description Mechanism of Action R&D Progress Inovio Pharmaceuticals, Inc. - Pipeline Products by Route of Administration Inovio Pharmaceuticals, Inc. - Pipeline Products By Mechanism of Action Inovio Pharmaceuticals, Inc. - Recent Pipeline Updates Inovio Pharmaceuticals, Inc. - Dormant Projects Inovio Pharmaceuticals, Inc. - Discontinued Pipeline Products Discontinued Pipeline Product Profiles PICTOVIR VGX-410C Inovio Pharmaceuticals, Inc. - Company Statement Inovio Pharmaceuticals, Inc. - Locations And Subsidiaries Head Office Other Locations & Subsidiaries Inovio Pharmaceuticals, Inc., Recent Developments Inovio Pharmaceuticals, Inc.- Press Release Jul 10, 2012: Inovio Pharma Initiates Phase I H1N1 Universal Influenza Vaccine Clinical Trial May 16, 2012: Inovio Pharma's Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses In Phase I Trial Full Table of Contents is available at: -- http://www.fastmr.com/ About Global Markets Direct Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. End
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Account Phone Number